A detailed history of Ims Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Ims Capital Management holds 104,938 shares of PFE stock, worth $3.05 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
104,938
Previous 102,909 1.97%
Holding current value
$3.05 Million
Previous $2.86 Million 2.84%
% of portfolio
1.35%
Previous 1.34%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 21, 2024

BUY
$25.26 - $29.6 $51,252 - $60,058
2,029 Added 1.97%
104,938 $2.94 Million
Q1 2024

Jun 12, 2024

BUY
$25.89 - $29.73 $86,084 - $98,852
3,325 Added 3.34%
102,909 $2.86 Million
Q4 2023

Apr 01, 2024

BUY
$26.13 - $33.94 $458,947 - $596,122
17,564 Added 21.41%
99,584 $2.87 Million
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $24,067 - $28,132
750 Added 0.92%
82,020 $2.72 Million
Q2 2023

Sep 13, 2023

BUY
$36.12 - $41.79 $530,386 - $613,644
14,684 Added 22.05%
81,270 $2.98 Million
Q1 2023

Sep 13, 2023

BUY
$39.39 - $51.28 $19,182 - $24,973
487 Added 0.74%
66,586 $2.72 Million
Q4 2022

Feb 22, 2023

BUY
$41.75 - $54.5 $6,471 - $8,447
155 Added 0.24%
66,099 $3.39 Million
Q3 2022

Nov 17, 2022

BUY
$43.76 - $53.42 $35,445 - $43,270
810 Added 1.24%
65,944 $2.89 Million
Q2 2022

Jul 13, 2022

BUY
$46.53 - $55.17 $2.48 Million - $2.94 Million
53,321 Added 451.38%
65,134 $3.42 Million
Q1 2022

Apr 08, 2022

BUY
$45.75 - $56.69 $35,913 - $44,501
785 Added 7.12%
11,813 $612,000
Q4 2021

Jan 05, 2022

BUY
$41.32 - $61.25 $49,749 - $73,745
1,204 Added 12.26%
11,028 $651,000
Q3 2021

Oct 07, 2021

BUY
$39.25 - $50.42 $33,558 - $43,109
855 Added 9.53%
9,824 $423,000
Q2 2021

Jul 07, 2021

SELL
$35.91 - $40.68 $1,041 - $1,179
-29 Reduced 0.32%
8,969 $351,000
Q1 2021

Apr 22, 2021

SELL
$33.49 - $37.77 $165,206 - $186,319
-4,933 Reduced 35.41%
8,998 $326,000
Q4 2020

Jan 12, 2021

SELL
$33.47 - $42.56 $208,551 - $265,191
-6,231 Reduced 30.9%
13,931 $513,000
Q3 2020

Nov 05, 2020

SELL
$31.75 - $37.25 $205,994 - $241,678
-6,488 Reduced 24.35%
20,162 $740,000
Q2 2020

Jul 15, 2020

BUY
$30.12 - $36.54 $55,993 - $67,927
1,859 Added 7.5%
26,650 $871,000
Q1 2020

Apr 03, 2020

BUY
$27.03 - $38.62 $478,268 - $683,342
17,694 Added 249.32%
24,791 $809,000
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $131 - $149
4 Added 0.06%
7,097 $278,000
Q3 2019

Oct 09, 2019

BUY
$32.49 - $42.13 $24,367 - $31,597
750 Added 11.82%
7,093 $255,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $56,838 - $63,816
-1,537 Reduced 19.51%
6,343 $275,000
Q1 2019

May 21, 2019

BUY
$37.5 - $41.2 $64,237 - $70,575
1,713 Added 27.78%
7,880 $335,000
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $100,637 - $114,737
-2,616 Reduced 29.78%
6,167 $269,000
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $106,167 - $128,774
3,080 Added 54.01%
8,783 $0
Q2 2018

Jul 26, 2018

SELL
$32.98 - $35.16 $48,876 - $52,107
-1,482 Reduced 20.63%
5,703 $207,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $27,705 - $29,396
833 Added 13.11%
7,185 $260,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $196,912 - $216,920
6,352
6,352 $227,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ims Capital Management Portfolio

Follow Ims Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ims Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Ims Capital Management with notifications on news.